Sorrento Therapeutics Inc.

06/11/2021 | Press release | Distributed by Public on 06/11/2021 07:02

Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver[...]